Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nifedipine and experimental cardioprotection.

W G Nayler1, J J Liu, S Panagiotopoulos

  • 1Department of Medicine, University of Melbourne, Austin Hospital, Victoria, Australia.

Cardiovascular Drugs and Therapy
|August 1, 1990
PubMed
Summary

Calcium antagonists show cardioprotective effects, particularly when administered prophylactically. Their effectiveness in protecting the heart during ischemia depends on precise timing and understanding cellular mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Test of CP Symmetry in the Neutral Decays of Λ via J/ψ→ΛΛ[over ¯].

Physical review letters·2026
Same author

Precise Measurement of the Chromoelectric Dipole Moment of the Charm Quark.

Physical review letters·2026
Same author

Precise Measurement of Matter-Antimatter Asymmetry with Entangled Hyperon-Antihyperon Pairs.

Physical review letters·2026
Same author

Observation of Λ[over ¯]p→K^{+}π^{+}π^{-}π^{0} and Λ[over ¯]p→K^{+}π^{+}π^{-}2π^{0}.

Physical review letters·2026
Same author

First Measurement of the D_{s}^{+}→K^{0}μ^{+}ν_{μ} Decay.

Physical review letters·2026
Same author

Observation of the Electromagnetic Radiative Decays of the Λ(1520) and Λ(1690) to γΣ^{0}.

Physical review letters·2026

Area of Science:

  • Cardiovascular Pharmacology
  • Ischemia-Reperfusion Injury

Background:

  • Experimental studies suggest calcium antagonists may protect the myocardium from ischemia and reperfusion injury.
  • The timing of calcium antagonist administration is crucial for cardioprotection.

Purpose of the Study:

  • To investigate the cardioprotective potential of calcium antagonists.
  • To explore the role of timing in the efficacy of calcium antagonists like nifedipine.
  • To elucidate the mechanisms underlying ischemia-reperfusion injury and the interaction with calcium channels.

Main Methods:

  • Utilized animal models to simulate ischemia and postischemic reperfusion.
  • Administered nifedipine prophylactically to assess its protective effects.
  • Quantified myocardial protection through measures like left ventricular function preservation.

Related Experiment Videos

  • Investigated the interaction between endothelial-derived peptide ET, calcium channels, and dihydropyridine-based blockers.

    • Main Results:

    • Prophylactic administration of nifedipine demonstrated a protective effect against both short and long episodes of ischemia.
    • Protection was evidenced by the preservation of left ventricular function.
    • Endothelin (ET) binding sites on cardiac membranes increase during ischemia.
    • ET promotes calcium influx via voltage-sensitive channels independently of dihydropyridine sites, but this influx is inhibited by dihydropyridine blockers.

    Conclusions:

    • Calcium antagonists, exemplified by nifedipine, can be cardioprotective when administered prophylactically.
    • Understanding the detailed sequence of events in ischemia-reperfusion and calcium channel interactions is essential for optimizing therapeutic use.
    • Endothelin plays a role in ischemia-induced calcium influx, which can be modulated by dihydropyridine-based calcium channel blockers.